02.10.09: Proteonomix, Inc. (PROT) Announces Definitive Agreement for Sale of Its Stem Cell Derived Cosmeceutical Products With Two Companies Headquartered in China
01.15.09: International Business Times announces Proteonomix, Inc.(PROT) is "One to Watch"
01.05.09:Proteonomix, Inc.(PROT) announces the appointment of Steven Byle to its Board of Directors effective January 15, 2009.
12.15.08: Proteonomix, Inc. Announces the Publication of Research on Use of Umbilical Cord Blood in Growing Undifferentiated Embryonic Stem Cells
12.08.08:Proteonomix, Inc. Announces That Its Subsidiary, Proteoderm, Inc., Has Entered Into a Letter of Intent With Sinoquest Investment Limited for the Licensing, Purchase and Distribution of Proteoderm's Co.